An overview of lockdown measures, vaccination rollout and other treatment strategies used against COVID-19 in the past triennium since the start of the global pandemic in the United Kingdom
Main Article Content
Abstract
In December 2019 there was a novel outbreak in Wuhan, China where an unknown respiratory disease known as SARS-COV-2 (COVID-19) started to spread rapidly across the world. In March 2020 the World Health Organisation declared a global pandemic. Over the next few years, the United Kingdom began adapting specific lockdown measures to prevent the spread of the disease, where a vaccination programme was started in December 2020 across the country to help prevent severity and reduce the rate of infection. Since the start of the pandemic, health care professionals have continued to work on effective treatment strategies to help relieve the stress on the health systems and manage the symptoms of the disease across the nation.
Keywords:
COVID-19, lockdown measures, vaccination rollout and other treatment strategies used against COVID-19, global pandemic, global pandemic in the United Kingdom
Article Details
How to Cite
DOWLING, Carl.
An overview of lockdown measures, vaccination rollout and other treatment strategies used against COVID-19 in the past triennium since the start of the global pandemic in the United Kingdom.
Medical Research Archives, [S.l.], v. 11, n. 1, jan. 2023.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/3500>. Date accessed: 21 nov. 2024.
doi: https://doi.org/10.18103/mra.v11i1.3500.
Section
Research Articles
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1) World Health Organisation Rolling Updates on Coronavirus Disease (COVID-19) 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen Accessed 15th November 2022.
2) European Centre for Disease Prevention and Control. Data on Country Response Measures to COVID-19. 2022. https://www.ecdc.europa.eu/en/publications-data/download-data-response-measures-covid-19 Accessed 15th November 2022.
3) Joffe, S. Evaluating SARS-COV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines. The Journal of the American Medical Association. 325 (3) 2021. https://doi.org/10.1001/jama.2020.25127
4) Worldometer. United Kingdom. 2022. https://www.worldometers.info/coronavirus/country/uk/ Accessed 18th November 2022.
5) Gov.uk (2021) COVID-19 Response-Spring. (Summary) Roadmap out of Lockdown. 2021. https://www.gov.uk/governent/publications/covid-19-response-spring-2021/covid-19-response-spring-2021-summary#roadmap-out-of-lockdown Accessed 20th November 2022
6) British Foreign Policy Group. COVID-19 Timeline. 2019. https://bfpg.co.uk/2020/04/covid-19-timeline/ Accessed 20th November 2022.
7) Gov.uk. COVID-19 Response-Summer 2021: Moving to Step 4 of the Roadmap. 2021. https://www.gov.uk/government/publications/covid-19-response-summer-2021-roadmap/moving-to-step-4-of-the-roadmap Accessed 20th November 2022.
8) Dolgin, E. The Tangled History of mRNA Vaccines. Nature. 2021. https://doi.org/10.1038/d41586-021-02483-w
9) The World Health Organisation. Coronavirus Disease (COVID-19): Vaccines. 2022. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccines?adgroupsurvey=%7Badgroupsurvey%7D&gclid=Cj0KCQiAg_kbBhDLARIsANx7wAx3Pr0iEOfS7UQ8Ipmimjh0qQBYXIIIJV-tDPjcoyDnJje1DUJ-n84aAmWqEALw_wcB Accessed 22nd November 2022.
10) Gov.uk. Coronavirus Vaccine – Summary of Yellow Card Reporting. 2022. https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-summary-of-yellow-card-reporting Accessed 22nd November 2022.
11) British Heart Foundation. Myocarditis and Covid-19 Vaccines: Should You Be Worried. 2022. https://www.bhf.org.uk/informationsupport/heart-matters-magazine/news/coronavirus-and-your-health/coronavirus-vaccine-your-questions-answered/myocarditis-and-covid-19-vaccines-should-you-be-worried Accessed 24th November 2022.
12) Gov.uk. The Yellow Card Scheme: Guidance for Healthcare Professionals, Patients and the Public.2021. https://www.gov.uk/guidance/the-yellow-card-scheme-guidance-for-healthcare-professionals Accessed 24th November 2022.
13) Gov.uk. Vaccinations in the UK: People Vaccinated. 2022. https://coronavirus.data.gov.uk/details/vaccinations Accessed 25th November 2022.
14) Gov.uk. Health and Wellbeing During Coronavirus: Selected NHS Patients to Access Coronavirus Treatment Remdesivir. 2020. https://www.gov.uk/government/news/selected-nhs-patients-to-access-coronavirus-treatment-remdesivir Accessed 25th November 2022.
15) National Health Service. About Remdesivir. 2022. https://www.nhs.uk/medicines/remdesivir-veklury/about-remdesivir/ Accessed 25th November 2022.
16) Beigel, H, J. Tomashek, M, k. Dodd, E, L. Mehta, K, A. Zingman, S, B. Kalil, C, A. Hohmann, E. Chu, Y, H. Luetkemeyer, A. Kline, S. De-Castilla, L, D. Finburg, W, R. Dierberg, K. Tapson, V. Hsieh, L. Patterson, F, T. Paredes, R. Sweeney, A, D. Short, R, W. Touloumi, G. Lye, C, D. Ohmagari, N. Oh, D, M. Ruiz-Palacios, M, G. Benfield, T. Fatkenheuer, G. Kortepeter, G, M. Atmar, L, R. Creech, B. Lundgren, J. Babiker, G, A. Pett, S. Neaton, D, J. Burgess, H, T. Bonnett, T. Green, M. Makowski, M. Osinusi, A. Nayak, S. Lane, C, H. Remdesivir For the Treatment of Covid-19 – Final Report. The New England Journal of Medicine. 2020. https://doi.org/10.1056/NEJMoa2007764
17) United Kingdom Research and innovation (2021) Leading the UK-EU Remdesivir Study. 2021. https://www.ukri.org/news-and-events/tackling-the-impact-of-covid-19/our-global-contribution/leading-the-uk-eu-remdesivir-study/ Accessed 28th November 2022.
18) United Kingdom Research and Innovation. The RECOVERY Trial. 2022. https://www.ukri.org/news-and-events/tackling-the-impact-of-covid-19/vaccines-and-treatments/recovery-trial-identifies-covid-19-treatments/ Accessed 8th December 2022.
19) National Health Service (2020) Dexamethasone tablets and Liquid. Available at https://www.nhs.uk/medicines/dexamethasone-tablets-and-liquid/
20) Moore, N. Carleton, B. Blin, P. Bosco-Levy, P. Droz, C. Does Ibuprofen Worsen COVID-19. Drug Safety. 2020. https://doi.org/10.1007/s40264-020-00953-0
21) Torjen, I. Covid-19: Ibuprofen Can be Used for Symptoms, says UK Agency, but Reasons for Change in Advice are Unclear. The British Medical Journal. 2020. https://doi.org/10.1136/bmj.m1555
22) Kragholm, K. Torp-Pedersen, C. Non-Steroidal Anti-Inflammatory Drug use in COVID-19. The Lancet: Rheumatology. 3 (7) 2020. https://doi.org/10.1016/s2665-9913(21)00144-2
2) European Centre for Disease Prevention and Control. Data on Country Response Measures to COVID-19. 2022. https://www.ecdc.europa.eu/en/publications-data/download-data-response-measures-covid-19 Accessed 15th November 2022.
3) Joffe, S. Evaluating SARS-COV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines. The Journal of the American Medical Association. 325 (3) 2021. https://doi.org/10.1001/jama.2020.25127
4) Worldometer. United Kingdom. 2022. https://www.worldometers.info/coronavirus/country/uk/ Accessed 18th November 2022.
5) Gov.uk (2021) COVID-19 Response-Spring. (Summary) Roadmap out of Lockdown. 2021. https://www.gov.uk/governent/publications/covid-19-response-spring-2021/covid-19-response-spring-2021-summary#roadmap-out-of-lockdown Accessed 20th November 2022
6) British Foreign Policy Group. COVID-19 Timeline. 2019. https://bfpg.co.uk/2020/04/covid-19-timeline/ Accessed 20th November 2022.
7) Gov.uk. COVID-19 Response-Summer 2021: Moving to Step 4 of the Roadmap. 2021. https://www.gov.uk/government/publications/covid-19-response-summer-2021-roadmap/moving-to-step-4-of-the-roadmap Accessed 20th November 2022.
8) Dolgin, E. The Tangled History of mRNA Vaccines. Nature. 2021. https://doi.org/10.1038/d41586-021-02483-w
9) The World Health Organisation. Coronavirus Disease (COVID-19): Vaccines. 2022. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccines?adgroupsurvey=%7Badgroupsurvey%7D&gclid=Cj0KCQiAg_kbBhDLARIsANx7wAx3Pr0iEOfS7UQ8Ipmimjh0qQBYXIIIJV-tDPjcoyDnJje1DUJ-n84aAmWqEALw_wcB Accessed 22nd November 2022.
10) Gov.uk. Coronavirus Vaccine – Summary of Yellow Card Reporting. 2022. https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-summary-of-yellow-card-reporting Accessed 22nd November 2022.
11) British Heart Foundation. Myocarditis and Covid-19 Vaccines: Should You Be Worried. 2022. https://www.bhf.org.uk/informationsupport/heart-matters-magazine/news/coronavirus-and-your-health/coronavirus-vaccine-your-questions-answered/myocarditis-and-covid-19-vaccines-should-you-be-worried Accessed 24th November 2022.
12) Gov.uk. The Yellow Card Scheme: Guidance for Healthcare Professionals, Patients and the Public.2021. https://www.gov.uk/guidance/the-yellow-card-scheme-guidance-for-healthcare-professionals Accessed 24th November 2022.
13) Gov.uk. Vaccinations in the UK: People Vaccinated. 2022. https://coronavirus.data.gov.uk/details/vaccinations Accessed 25th November 2022.
14) Gov.uk. Health and Wellbeing During Coronavirus: Selected NHS Patients to Access Coronavirus Treatment Remdesivir. 2020. https://www.gov.uk/government/news/selected-nhs-patients-to-access-coronavirus-treatment-remdesivir Accessed 25th November 2022.
15) National Health Service. About Remdesivir. 2022. https://www.nhs.uk/medicines/remdesivir-veklury/about-remdesivir/ Accessed 25th November 2022.
16) Beigel, H, J. Tomashek, M, k. Dodd, E, L. Mehta, K, A. Zingman, S, B. Kalil, C, A. Hohmann, E. Chu, Y, H. Luetkemeyer, A. Kline, S. De-Castilla, L, D. Finburg, W, R. Dierberg, K. Tapson, V. Hsieh, L. Patterson, F, T. Paredes, R. Sweeney, A, D. Short, R, W. Touloumi, G. Lye, C, D. Ohmagari, N. Oh, D, M. Ruiz-Palacios, M, G. Benfield, T. Fatkenheuer, G. Kortepeter, G, M. Atmar, L, R. Creech, B. Lundgren, J. Babiker, G, A. Pett, S. Neaton, D, J. Burgess, H, T. Bonnett, T. Green, M. Makowski, M. Osinusi, A. Nayak, S. Lane, C, H. Remdesivir For the Treatment of Covid-19 – Final Report. The New England Journal of Medicine. 2020. https://doi.org/10.1056/NEJMoa2007764
17) United Kingdom Research and innovation (2021) Leading the UK-EU Remdesivir Study. 2021. https://www.ukri.org/news-and-events/tackling-the-impact-of-covid-19/our-global-contribution/leading-the-uk-eu-remdesivir-study/ Accessed 28th November 2022.
18) United Kingdom Research and Innovation. The RECOVERY Trial. 2022. https://www.ukri.org/news-and-events/tackling-the-impact-of-covid-19/vaccines-and-treatments/recovery-trial-identifies-covid-19-treatments/ Accessed 8th December 2022.
19) National Health Service (2020) Dexamethasone tablets and Liquid. Available at https://www.nhs.uk/medicines/dexamethasone-tablets-and-liquid/
20) Moore, N. Carleton, B. Blin, P. Bosco-Levy, P. Droz, C. Does Ibuprofen Worsen COVID-19. Drug Safety. 2020. https://doi.org/10.1007/s40264-020-00953-0
21) Torjen, I. Covid-19: Ibuprofen Can be Used for Symptoms, says UK Agency, but Reasons for Change in Advice are Unclear. The British Medical Journal. 2020. https://doi.org/10.1136/bmj.m1555
22) Kragholm, K. Torp-Pedersen, C. Non-Steroidal Anti-Inflammatory Drug use in COVID-19. The Lancet: Rheumatology. 3 (7) 2020. https://doi.org/10.1016/s2665-9913(21)00144-2